chrX-102937427-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001031834.1(RAB40AL):c.109G>A(p.Gly37Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00016 in 1,210,019 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 68 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001031834.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB40AL | NM_001031834.1 | c.109G>A | p.Gly37Ser | missense_variant | 1/1 | ENST00000218249.7 | NP_001027004.1 | |
LINC00630 | NR_146589.1 | n.1910-21221G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB40AL | ENST00000218249.7 | c.109G>A | p.Gly37Ser | missense_variant | 1/1 | 6 | NM_001031834.1 | ENSP00000218249.5 |
Frequencies
GnomAD3 genomes AF: 0.000161 AC: 18AN: 111736Hom.: 0 Cov.: 22 AF XY: 0.000118 AC XY: 4AN XY: 33896
GnomAD3 exomes AF: 0.000234 AC: 43AN: 183494Hom.: 0 AF XY: 0.000236 AC XY: 16AN XY: 67922
GnomAD4 exome AF: 0.000160 AC: 176AN: 1098234Hom.: 0 Cov.: 32 AF XY: 0.000176 AC XY: 64AN XY: 363588
GnomAD4 genome AF: 0.000161 AC: 18AN: 111785Hom.: 0 Cov.: 22 AF XY: 0.000118 AC XY: 4AN XY: 33955
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 24, 2024 | The c.109G>A (p.G37S) alteration is located in exon 1 (coding exon 1) of the RAB40AL gene. This alteration results from a G to A substitution at nucleotide position 109, causing the glycine (G) at amino acid position 37 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at